Comparable stake leader
Jorey Chernett
SEC ownership of OKYO Pharma Ltd
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001849296.
Disclosed value leader
Gabriele M. Cerrone
Comparable rows
17/21
Latest evidence
08 Jun 2026
- Public ticker
- OKYO on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jorey Chernett
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
17 of 21
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Jorey Chernett
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
08 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001849296
- Issuer location
- London, United Kingdom
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of OKYO Pharma Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jorey Chernett
Disclosed value leader
Gabriele M. Cerrone
Comparable rows
17/21
Latest evidence
08 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.5%
4 rows are not safely comparable across share classes.
13D/G row: Jorey Chernett
Showing 1-8 of 21 holder rows.
Quick read
Jorey Chernett leads the comparable SEC ownership view at 9.5%.
17 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jorey Chernett's linked filing trail.
Comparable ownership
Top 5
Jorey Chernett
9.5%
Sirenia Capital Management LP
7.7%
Woodline Partners LP
7%
Laura Natalia Monica Fonda
5%
Dauntless Investment Group, LLC
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 21 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
Chernett Jorey
|
9.5%
|
$11,824,823
3,802,194 shares
|
+$2,541,903 | 31 Dec 2025 |
| Sirenia Capital Management LP |
13D/G
|
7.7%
|
$6,202,703
4,054,054 shares
|
$0 | 31 Mar 2026 |
| Woodline Partners LP |
13F
13D/G
Company
|
7%
from 13D/G
|
$5,880,026
3,652,190 shares
|
— | 31 Mar 2026 |
| Laura Natalia Monica Fonda |
13D/G
|
5%
|
$3,856,902
1,928,451 shares
|
$0 | 22 Jul 2025 |
| Dauntless Investment Group, LLC |
13D/G
13F
Company
|
1.2%
|
$1,466,437
471,523 shares
|
-$6,066,133 | 31 Dec 2025 |
| Gabriele M. Cerrone |
3/4/5
Director, 10%+ Owner
|
41%
|
$35,325,436
21,352,832 shares
|
— | 08 Jun 2026 |
| Gary S. Jacob |
3/4/5
Chief Development Officer, Director
|
0.21%
|
$185,164
108,920 shares
|
— | 18 Mar 2026 |
| Maven Securities LTD |
13F
Company
|
2.3%
|
$1,892,611
1,175,535 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-9 of 9 reporting-owner rows connected to OKYO Pharma Ltd. Open a relationship link for the CIK-to-CIK filing trail.
Rows
9
Largest Forms 3/4/5 holder
Gabriele M. Cerrone
Net 12M change
$0
Latest report
08 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Gabriele M. Cerrone | Director, 10%+ Owner | $35,325,436 | Mixed | 08 Jun 2026 | ||
| Gary S. Jacob | Chief Development Officer, Director | $185,164 | Mixed | 18 Mar 2026 | ||
| John P. Brancaccio | Director | $50,133 | Mixed | 08 Jun 2026 | ||
| Keeren Rameshchandra Shah | Chief Financial Officer | $26,333 | Mixed | 08 Jun 2026 | ||
| Willy Jules Simon | Director | $25,535 | Mixed | 08 Jun 2026 | ||
| Bernard Denoyer | Director | Mixed | 08 Jun 2026 | |||
| Keeren Shah | Chief Financial Officer | Mixed | 16 May 2022 | |||
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER, Director | Mixed | 18 Mar 2026 | |||
| Flavio Mantelli | Chief Medical Officer | Mixed | 18 Mar 2026 |
Recent insider transactions for OKYO Pharma Ltd
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Bernard Denoyer | OKYO | Option | Award | 11% | 3,500 | 35,190 | 08 Jun 2026 | Direct | ||
| John P. Brancaccio | OKYO | Option | Award | 4.93% | 6,500 | 138,394 | 08 Jun 2026 | Direct | ||
| Willy Jules Simon | OKYO | Option | Award | 5.04% | 6,500 | 135,502 | 08 Jun 2026 | Direct | ||
| Keeren Rameshchandra Shah | OKYO | Option | Award | 7.92% | 40,000 | 544,819 | 08 Jun 2026 | Direct | ||
| Gabriele M. Cerrone | OKYO | COMMON STOCK | Award | 2.85% | 300,000 | 10,826,416 | 08 Jun 2026 | Via Panetta Partners Limited |
* marks a reported price that did not pass the local price check.